Karimah Es Sabar serves as Executive at CAPRICOR THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Karimah Es Sabar has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 5, 2026 involved receiving (via award) 15,500 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 5, 2026 | CAPR | $0 | Award | 15,500 | $N/A | Discretionary |
Karimah Es Sabar currently holds 15,500 shares of CAPRICOR THERAPEUTICS, INC. (CAPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karimah Es Sabar has been a net neutral trader of CAPR stock. They have purchased $0 and sold $0 worth of shares.
Karimah Es Sabar's most recent insider trade was on Jan 5, 2026, when they sold 15,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted